UNITED THERAPEUTICS Corp
Last 30 daysNo qualifying insider buying. Sales: $114.49M by 3 insiders.
Chairperson & CEO
Common Stock
Excluded from the common-share buying signal. See trade details.
| Reporting insider | Security / transaction |
|---|
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
| Amount / price |
|---|
| Value |
|---|
| Traded / disclosed |
|---|
| Source |
|---|
| Chairperson & CEO | Common StockPurchase10b5-1Excluded from purchase score | 1,500$575.96 / share | $863.95K | May 26Filed May 27 · 1d later | SEC filing |
United Therapeutics Corporation - Common Stock (UTHR) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House memberUnited Therapeutics Corporation - Common Stock (UTHR) · Stock
The filing reports a purchase for a spouse.
Lisa McClainReporting House memberUnited Therapeutics Corporation - Common Stock (UTHR) · Stock
The filing reports a sale for a spouse.
Lisa McClainReporting House member